Page last updated: 2024-11-06

phenyliodosodiacetate

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Phenyliodosodiacetate (PIDA) is a versatile hypervalent iodine reagent commonly used in organic synthesis. It is a white, crystalline solid, prepared by oxidizing iodobenzene with sodium hypochlorite in the presence of acetic acid. PIDA serves as an effective oxidizing agent, capable of performing various transformations, including the oxidation of alcohols, aldehydes, and amines, as well as the dihydroxylation of alkenes. The compound's reactivity stems from the presence of the hypervalent iodine atom, which can act as an electrophilic or oxidizing agent. Research surrounding PIDA focuses on its applications in organic synthesis, particularly its ability to introduce oxygen functionalities into molecules and promote selective oxidation reactions. These properties make PIDA a valuable tool for the synthesis of complex organic molecules and the development of novel synthetic methodologies.'

phenyliodosodiacetate: glycol-cleaving reagent used with amino alcohols in ring opening & Mannich base reactions; structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID76724
CHEMBL ID3391738
SCHEMBL ID47350
MeSH IDM0053070

Synonyms (64)

Synonym
AC-1473
iodine, bis(acetato-.kappa.o)phenyl-
((diacetoxy)iodo)benzene
iodobenzene diacetate
wln: 1vo-i-r &ov1 &5/10
phenyliodine diacetate
nsc-23801
(diacetoxyiodo)benzene
phenyliodoso diacetate
phenyliodoso acetate
benzene, diacetate
bis(acetato)phenyliodine
nsc23801
iodine, bis(acetato-o)phenyl-
phenyliodo diacetate
iodosobenzene diacetate
benzene, (diacetoxyiodo)-
3240-34-4
nsc226375
nsc-226375
iodine, bis(acetato-kappao)phenyl-
nsc 23801
bis(acetato-o)phenyliodine
benzene, iodoso-, diacetate
einecs 221-808-1
phenyliodosodiacetate
phenyliodosyl diacetate
phenyliodine(iii) diacetate
benzene, (dihydroxyiodo)-, diacetate
(diacetoxyiodo)benzene, 98%
AKOS005146479
I0330
pida
A25390
diacetoxyiodosobenzene; iodobenzene i,i-diacetate
BBL009751
bis(acetato-?o)phenyliodine
diacetoxy(phenyl)iodine
bis(acetyloxy)(phenyl)-lambda~3~-iodane
STL145789
FT-0600923
AM20120551
SCHEMBL47350
daib
bis(acetyloxy)(phenyl)-lambda3-iodane
phi(oac)2
[bis(acetoxy)iodo]benzene
diacetoxy(phenyl)-iodane
DTXSID0062929
phenyl-l3-iodanediyl diacetate
W-106842
mfcd00008692
(acetyloxy)(phenyl)-??-iodanyl acetate
F8881-0984
CHEMBL3391738
CS-W011998
Q3025837
bis(acetoxy)phenyliodane
[acetyloxy(phenyl)-lambda3-iodanyl] acetate
iodobenzene diacetate;(diacetoxyiodo)benzene
(acetyloxy)(phenyl)-lambda3-iodanyl acetate
(acetyloxy)(phenyl)-lambda(3)-iodanyl acetate
EN300-43675
BP-31135
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (16)

TimeframeStudies, This Drug (%)All Drugs %
pre-19902 (12.50)18.7374
1990's0 (0.00)18.2507
2000's4 (25.00)29.6817
2010's9 (56.25)24.3611
2020's1 (6.25)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.27

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.27 (24.57)
Research Supply Index2.83 (2.92)
Research Growth Index5.11 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.27)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other16 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]